Recent Finacing
Recent Raise
Azevan Pharmaceuticals develops therapeutics to treat mood and behavior disorders, advancing two arginine vasopressin‑blocking programs targeting PTSD and depression toward Phase 2 clinical trials from its Lehigh University incubator.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor